Upcoming release provides solution for tracking documents associated with monitoring visits
As part of Wingspan’s commitment to advancing the state of the art in managing TMF completeness, the Wingspan eTMF’s newest release features improved planning for monitoring visit documents. Since the date and number of monitoring visits are not known at the beginning of the study, organizations often experience challenges in ensuring that all visit documents are collected in a timely manner. Wingspan eTMF solves this problem by creating placeholders for visit documents as the visits are scheduled.
If visit information is available in CTMS, Wingspan eTMF automatically creates placeholders for visit documents. Due dates for documents are automatically assigned based on the visit date and a document type specific offset. The actual monitoring visit reports can also be automatically imported from CTMS.
For organizations who do not have visit information available from CTMS, visits can be planned directly in the eTMF user interface.
With both approaches, changes in visit dates are automatically detected and the due dates for associated document automatically updated
The Wingspan eTMF Study Setup wizard already provides highly flexible, study-specific planning for TMFs, and the Event Tool allows planning of documents associated with trial events such as protocol amendments. By providing new capabilities such as visit document planning, Wingspan is focusing on
addressing the more advanced challenges associated in eTMF planning. As a result, Wingspan eTMF users have the most accurate view of eTMF completeness in the industry.
About Wingspan Technology, Inc.
Wingspan Technology, Inc. is the leading provider of life sciences and eClinical software solutions, including Wingspan eTMF and DocWay, the SharePoint/Documentum integration product suite. Wingspan's talented and knowledgeable engineering and project management teams offer in-depth industry knowledge and experience to companies in life sciences, pharmaceutical, financial services, and other fields
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.